Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma.

Autor: Mizumura K; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. Electronic address: mizumura.kenji@nihon-u.ac.jp., Gon Y; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan., Harada N; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Juntendo University, Tokyo, Japan., Yamada S; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan., Fukuda A; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan., Ozoe R; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan., Maruoka S; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan., Abe S; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Juntendo University, Tokyo, Japan., Takahashi K; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Juntendo University, Tokyo, Japan., Tanaka A; Division of Respiratory Medicine and Allergology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan., Sagara H; Division of Respiratory Medicine and Allergology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan., Akamatsu T; Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan., Shirai T; Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan., Masaki K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Fukunaga K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Kobayashi K; Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan., Nagase H; Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan., Miyahara N; Department of Medical Technology, Okayama University Academic Field of Health Sciences, Okayama, Japan., Kanehiro A; Social Medical Corporation Foundation of St. Francis Himeji St. Mary's Hospital, Hyogo, Japan., Kitamura N; Jinyu Clinic, Tokyo, Japan., Sugihara N; Jinyu Clinic, Tokyo, Japan., Kumasawa F; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan; Division of Respiratory Medicine, Akabane Central General Hospital, Tokyo, Japan., Terada-Hirashima J; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Hojo M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Chibana K; Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Tochigi, Japan., Tagaya E; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.

Publikováno v: Allergology international : official journal of the Japanese Society of Allergology [Allergol Int] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.

Effectiveness of BNT162b2 Against Infection, Symptomatic Infection, and Hospitalization Among Older Adults Aged ≥65 Years During the Delta Variant Predominance in Japan: The VENUS Study.

Autor: Mimura W; Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine., Ishiguro C; Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine., Terada-Hirashima J; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine., Matsunaga N; AMR Clinical Reference Center, National Center for Global Health and Medicine., Sato S; Clinical Research Center, Nagasaki University Hospital., Kawazoe Y; Clinical Research Center, Nagasaki University Hospital., Maeda M; Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences., Murata F; Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences., Fukuda H; Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences.

Publikováno v: Journal of epidemiology [J Epidemiol] 2024 Jun 05; Vol. 34 (6), pp. 278-285. Date of Electronic Publication: 2024 Jan 31.

Diagnostic accuracy of direct reverse transcription-polymerase chain reaction using guanidine-based and guanidine-free inactivators for SARS-CoV-2 detection in saliva samples.

Autor: Katsuno T; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: katsuno.takashi.jb@mail.hosp.go.jp., Kimura M; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Terada-Hirashima J; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Kazuyama Y; SB Coronavirus Inspection Center Corp., Tokyo, Japan., Ikeda M; SB Coronavirus Inspection Center Corp., Tokyo, Japan., Moriya A; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan., Kurokawa M; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan., Motohashi A; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan., Isaka E; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan., Morishita M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Kawajiri K; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Hakkaku K; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Saito S; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Terayama Y; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Sugiura Y; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Yamaguchi Y; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Takumida H; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Watanabe H; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Morita C; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Tsukada A; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Kusaba Y; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Tsujimoto Y; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Ishida A; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Sakamoto K; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Hashimoto M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Suzuki M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Takasaki J; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Izumi S; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Hojo M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Sugiyama H; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan., Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.

Publikováno v: Journal of virological methods [J Virol Methods] 2024 May; Vol. 326, pp. 114909. Date of Electronic Publication: 2024 Mar 05.

Relapse of COVID-19 and Viral Evolution in a Patient With Good Syndrome: A Case Report.

Autor: Iwasaki M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, JPN., Hashimoto M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, JPN., Takeuchi JS; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JPN., Kusaba Y; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, JPN., Kimura M; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JPN., Terada-Hirashima J; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, JPN., Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, JPN., Hojo M; Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, JPN.

Publikováno v: Cureus [Cureus] 2024 Jan 19; Vol. 16 (1), pp. e52592. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan.

Autor: Terada-Hirashima J; Department of Clinical Research Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.; Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan., Takamatsu Y; Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, Japan., Shimizu Y; Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Uemura Y; Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Takeuchi JS; Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Tomita N; Department of Clinical Research Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Matsuda K; Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, Japan., Maeda K; Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, Japan., Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Fukunaga A; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Ohmagari N; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan., Mikami A; Department of Clinical Research Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Sonoda K; Development Department, KM Biologics Co. Ltd, Kumamoto, Japan., Ujiie M; Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan., Mitsuya H; Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo, Japan., Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2193074. Date of Electronic Publication: 2023 Apr 13.